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Abstract
There is a growing concern both inside and outside the scientific community over the lack of reproducibility of experiments.
The depth and detail of reported methods are critical to the reproducibility of findings, but also for making it possible to
compare and integrate data from different studies. In this study, we evaluated in detail the methods reporting in a
comprehensive set of trypanosomiasis experiments that should enable valid reproduction, integration and comparison of
research findings. We evaluated a subset of other parasitic (Leishmania, Toxoplasma, Plasmodium, Trichuris and Schistosoma)
and non-parasitic (Mycobacterium) experimental infections in order to compare the quality of method reporting more
generally. A systematic review using PubMed (2000–2012) of all publications describing gene expression in cells and animals
infected with Trypanosoma spp was undertaken based on PRISMA guidelines; 23 papers were identified and included. We
defined a checklist of essential parameters that should be reported and have scored the number of those parameters that
are reported for each publication. Bibliometric parameters (impact factor, citations and h-index) were used to look for
association between Journal and Author status and the quality of method reporting. Trichuriasis experiments achieved the
highest scores and included the only paper to score 100% in all criteria. The mean of scores achieved by Trypanosoma
articles through the checklist was 65.5% (range 32–90%). Bibliometric parameters were not correlated with the quality of
method reporting (Spearman’s rank correlation coefficient ,20.5; p.0.05). Our results indicate that the quality of methods
reporting in experimental parasitology is a cause for concern and it has not improved over time, despite there being
evidence that most of the assessed parameters do influence the results. We propose that our set of parameters be used as
guidelines to improve the quality of the reporting of experimental infection models as a pre-requisite for integrating and
comparing sets of data.
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Introduction
In this study, we evaluated the reported information on
experimental methods in published infectious disease experiments
that should enable a valid comparison of research findings. It has
been claimed that most published research findings are false [1]
and concern about this is spreading beyond the scientific
community, making the cover of The Economist recently [2],
and potentially undermining public trust in science. Amongst the
scientific community there is a growing concern over the related
problem of lack of reproducibility [3,4]. The depth and detail of
reported methods directly contributes to the replicability, repro-
ducibility and comparability of experimental work. Replicability is
the exact repetition of an experiment to obtain the same results,
reproducibility is the repetition of an experiment with small
modifications, e.g. the changes that will inevitably occur when
conducting the same experiment in different laboratories [5,6]. If
results are replicable but not reproducible they may be of little
value since they are likely to be idiosyncratic to the precise
conditions used and further inference from the results will be
problematic. Comparability is essential to facilitate translational
discoveries by making it possible to aggregate data from multiple
experiments in a single meta-analysis and answering questions not
addressed by the original investigators. The information reported
in the Materials & Methods section of an article plays a
fundamental role in achieving this aim. In the biomedical field,
for instance, the Uniform Guidelines of the International
Committee of Medical Journal Editors state that authors should
include technical information in sufficient detail to allow the
experiment to be repeated by other workers [7]. However, the
guidelines are not strictly adhered to and, consequently, the lack of
methodological information can make the tasks of replicating,
reproducing or comparing results by non-specialists in a field
problematic.
Over the past decade sets of minimum items of information
have been published that should be reported about a dataset or an
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experimental process [8]. This allows readers not only to
unambiguously interpret and critically evaluate the conclusions
reached, but also to potentially replicate, reproduce and compare
the experiments. The minimum information checklist or guidelines
seek to promote transparency in experimental reporting, enhance
accessibility to data and support effective quality assessment, which
increases the general value of data, and therefore of the scientific
evidence. In this sense, some standard initiatives, such as the
Minimum Information About a Microarray Experiment (MIAME)
[9] and the Minimum Information About a Proteomics Experi-
ment (MIAPE) [10], have been adopted by several journals, such
as Nature Genetics or the Journal of Proteomics, as a requirement
for publication.
To address the issue of reproducibility in the context of
biomedical experiments, we looked at experimental infection
models with a particular focus on the trypanosomiases, which are a
widespread group of complex infectious diseases caused by
flagellated protozoa of the genus Trypanosoma. These infections
affect humans and animals, often with fatal consequences unless
treated. In humans, African (sleeping sickness) and American
(Chagas disease) trypanosomiases are responsible for considerable
morbidity and mortality, affecting millions of people every year
[11–13]. Moreover, human economic welfare in Africa is also
affected by these diseases due to loss of livestock production [14].
The outcome of infection with both American and African
trypanosomes depends on both the host and parasite genetic
background as well as on environmental variation [15–17]. In
addition, the trypanosomiases have been labelled as ‘‘neglected’’
because their study hovers in the margins of international health;
there is a smaller investment in their research and development
and as a result they are less well understood. Hence, an important
task is to integrate and compare data from their studies in order to
augment the value of this data.
Many studies have been carried out to explore the physiopa-
thology of sleeping sickness and Chagas disease, as well as their
genetics. At the time of writing, a PubMed search from 2000–2013
retrieved 1558 and 4248 journal articles containing the MeSH
(Medical Subject Headings) terms ‘‘Trypanosomiasis, African’’
and ‘‘Chagas disease’’, respectively. Despite the large amount of
published research, our understanding of the underlying mecha-
nisms involved in these diseases is still limited. It is likely that this
can be partly explained by the inherent difficulty in making direct
comparisons between the results of independent Trypanosoma
infection experiments.
Currently we have data from studies carried out in experimental
models of trypanosomiasis. However, a considerable part of this
evidence is controversial or contradictory; probably stemming
from differences in pre-analytical, analytical and post-analytical
variables, as well as experimental design and data analysis. In
Chagas diseases, for instance, the role played by the Th17 immune
response, T regulatory cells and Nitric Oxide may be critical to the
outcome of infection [18–20] or these immune factors may have
opposing effects or not be required [21–23]. Therefore, it is
important to know how the data were produced in order to deal
not only with the biological complexity of these diseases, but also
to permit the replicability, reproducibility and, especially in the
case of contradictory results, the comparability of research
findings. In order to assess how easy it would be to replicate,
reproduce or compare experiments we have undertaken a
systematic review of all publications describing gene expression
experiments in model organisms infected with these parasites. We
have defined a list of essential parameters describing the parasite,
the host and the infection that should be reported and for each
experiment we have scored the number of those parameters that
are reported. In order to determine whether our findings can be
generalised to other diseases we have used the same method to
assess a subset of papers on Leishmania, Toxoplasma and
Plasmodium. A subset of papers that utilised the intestinal
helminth parasite Trichuris muris or Schistosoma sp. were used
as a comparative control in order to determine the relevance of the
checklist in a non-protozoan parasite infection model. In addition,
a subset of papers from a non-parasitic infection model
(Mycobacterium) were used in order to determine whether this
issue is unique to parasitology or has wider implications.
Results
Search strategy
A total of 23 papers on Trypanosoma experiments were
identified for inclusion in the review. The search in PubMed
provided a total of 5878 references with the MeSH term
‘‘Trypanosomiasis’’, of which 104 were related with terms
‘‘Genes’’ and ‘‘Proteins’’, 35 with ‘‘Microarray Analysis’’, and 27
with ‘‘Proteomics’’. After adjusting for duplicates 163 remained.
The abstracts of these papers were reviewed manually and 139
were discarded because they did not meet the selection criteria
(Figure 1 and Table 1). The remaining 23 references [24–46] were
the corpus of papers identified that reported on gene expression
profiling in the host due to an experimental Trypanosoma
infection. A subset of 10 articles each of the closely related
protozoan parasites Leishmania [47–56], Toxoplasma [57–66] and
Plasmodium [67–76] were included for comparison. In addition,
10 articles of Trichuris [77–86] and Schistosoma [87–96] parasitic
worm experiments, and 10 articles of Mycobacterium [97–106]
experiments as a non-parasitic infection model were included in
order to contrast the quality of method reporting in Trypanosoma
experiments to other models and to determine the applicability of
the checklist to different experimental systems.
Quality of method reporting
To assess the quality of method reporting in Trypanosoma
experiments, each paper was checked for reporting of information
in three domains: the parasite, the host and the experimental
infection. The scores are listed in Tables S1, S2 and S3. A mean of
65.5% (SD =15.12%) of the information required to reproduce
an experiment was reported in this set of papers. No article met all
criteria that should be reported in a Trypanosoma experiment
according to our checklist (range 32–90%), although two studies
[27,41] scored at 100% out of the available criteria for the parasite
and host domains (Tables S1 and S2). The number of articles that
met all criteria was higher in the parasite domain (6 out of 23
articles), however the number of criteria met by all the articles was
higher in the host domain (7 out of 12 criteria) (Figure 2, Tables
S1, S2 and S3). In the experimental infection domain, the
inoculum was the only criteria met by all articles, whereas the
viability criteria for both cells and parasites were not met in full by
any of the studies (Table S3).
Bibliometric indices
Different journals have different criteria for publication in order
to enhance the quality of research and to prevent publication of
poor findings. However, these safeguards are not always successful;
limited space for the method section or forms of bias in the peer
review process are some of the issues that have generated serious
discussion in several scientific journals [107]. Thus, to discover
whether there was an association between bibliometric parameters
and the quality of method reporting in Trypanosoma experiments,
the journal impact factor, the h-index of the corresponding author
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and the number of citations of the article were compared with the
scores for the quality of method reporting. No correlation was
observed between method reporting scores and impact factor or h-
index (Figures 3A and 3B). However, a significant negative
correlation was observed when the scores for method reporting
were correlated with the number of citations of the article obtained
from Google Scholar (r=20.42; p=0.044, n= 23) but not with
citations from the Web of Sciences (r=20.35; p=0.105, n= 23)
(Figure 3C). Interpretation of this observation is confounded by
the tendency of older papers to have more citations (Google
Scholar: r=20.40; p=0.057, n= 23; Web of Sciences: r=20.42;
p=0.046, n = 23; Figure 3D). There was no correlation between
the quality of method reporting and the year of publication, which
remained constant during the last 12 years (Figure 4).
In order to identify relations between the quality of methods
reporting in Trypanosoma experiments and the experience of the
journal with publishing papers about trypanosomiasis, we com-
pared the scores achieved for the articles (arithmetic mean was
calculated for two or more papers) with the number of articles
about trypanosomiasis in the journal in which the articles were
published. This comparison showed that the number of articles
published in any one journal about trypanosomiasis was not
associated with an increase in the quality of methods reporting.
The journals with most and fewest articles published about
trypanosomiasis between 2000 and 2012 were the American
Journal of Tropical Medicine and Hygiene with 172 papers and
Genes and Immunity with only three papers (Table S4).
Nonetheless, the article that received the lowest score in the
reported information (32%) was published in the American
Journal of Tropical Medicine and Hygiene [40], whereas the
mean score for articles published in Genes and Immunity [36] was
almost double this value (60%) (Figure 5).
Comparison with other parasitic diseases
In order to test whether our observations about the quality of
method reporting were a general phenomenon or whether they
were specific to trypanosomiasis we evaluated 10 articles each on
Leishmania, Toxoplasma and Plasmodium; these diseases were
chosen because they are also complex and considered public
health issues. As in the articles about Trypanosoma experiments,
Figure 1. Study selection process for Trypanosoma studies.
doi:10.1371/journal.pone.0101131.g001
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no article about Leishmania, Toxoplasma and Plasmodium
experiments met all criteria that should be reported on our
checklist, although one publication on Leishmania [49] scored
100% for the parasite and host domains (Table S5 and S6). There
was no significant difference in the percentage of reported
information between Trypanosoma, Leishmania, Toxoplasma and
Table 1. Studies characteristics in trypanosomiasis: parasite species, experimental infection models and aims of the studies.
Author, year and journal Parasite Infection model Aim
Amin et al., 2010 Am J Trop
Med Hyg
T. b. brucei Mouse Discover genes differentially expressed in brain of mice at the early and late
stages of T. b. brucei infection.
Chessler et al., 2009 J Immunol T. cruzi Mouse Examine the initial host-parasite interaction in vivo by monitoring changes in
global host mRNA levels at the site of intradermal infection of mice with T.
cruzi.
Costales et al., 2009 BMC Genomics T. cruzi Cell line Investigate the impact of intracellular T. cruzi infection on host cell gene
expression.
Garg at al., 2004 Biochem J T. cruzi Mouse Characterise the cardiac metabolic response to T. cruzi infection and
progressive disease severity.
Genovesio et al., 2011 PLoS One T. cruzi Cell line Search for human cell factors that play a role during infection by the
protozoan parasite T. cruzi.
Goldenberg et al., 2009 Microbes
Infect
T. cruzi Primary culture
(Cardiomyocytes)
Examine gene profiling of T. cruzi-infected cardiac myocytes.
Graefe et al., 2006 PLoS One T. cruzi Mouse Analyse genome wide expression differences in the spleen at the point at
which the immune response diverges between susceptible and resistant
mice, and then match the genomic localisation of differential expressed
genes with mapped susceptibility loci.
Hashimoto et al., 2005 Int
J Parasitol
T. cruzi Cell line Report the time-course of transcriptional changes in apoptosis-related genes
responsive to Fas stimulation in T. cruzi infected cells.
Hill et al., 2005 Vet Immunol
Immunopathol
T. congolense Cattle Investigate the transcriptional response of susceptible cattle to trypanosome
infection.
Kierstein et al., 2006 Genes Immun T. congolense Mouse Explore the ability of more integrated analysis of genetics of
trypanotolerance underlying the response to infection and identify pathways
involved in trypanotolerance.
Li et al., 2009 Parasitol Res T. evansi Mouse Investigate the global gene expression in the liver and spleen of mice after
infection with T. evansi.
Li et al., 2011 Exp Parasitol T. b. brucei Mouse Examine the effects of T. b. brucei infection on the liver and spleen of mice at
the molecular level.
Lopez et al., 2008 J Immunol T. b. rhodesiense Mouse, primary
culture and cell line
Define the spectrum of host innate immune response genes that are induced
during early trypanosome infection in macrophages ex vivo as well as
macrophages treated in vitro with sVSG.
Manque et al., 2011 Infect Immun T. cruzi Primary culture
(Cardiomyocytes)
Characterise the global response of murine cardiomyocytes after infection by
trypomastigotes in a carefully controlled progression.
Meade et al., 2009 Mol Immunol T. congolense Cattle Determine the expression levels of AMP and APP genes in PBMC isolated
from trypanotolerant and trypanosusceptible cattle experimentally infected
with T. congolense.
Mekata et al., 2012 Parasite
Immunol
T. evansi Mouse Determine what kinds of inflammatory molecules play roles in the
pathogenicity of T. evansi infection.
Mukherjee et al., 2003 Parasitol Res T. cruzi Mouse Identify genes that could contribute to cardiac remodelling as a result of T.
cruzi infection.
Mukherjee et al., 2008 Genomics T. cruzi Mouse Report the patterns of gene expression during the development of murine
chagasic heart disease, encompassing several time points in the transition
from acute to chronic disease.
Noyes et al., 2009 PLoS One T. congolense Mouse Assess the parameters that influence anaemia in murine T. congolense
infections using mouse strains that differ in their susceptibility to
trypanosomiasis.
O’Gorman et al., 2009 BMC
Genomics
T. congolense Cattle Catalogue and analyse gene expression changes in PBMC from
trypanotolerant and trypanosusceptible cattle following an experimental
challenge with T. congolense.
Soares et al., 2010 J Infect Dis T. cruzi Mouse Determine alterations in gene expression in the myocardium of mice
chronically infected with T. cruzi.
Soares et al., 2011 Cell Cycle T. cruzi Mouse Evaluate the efficacy of transplantation of BMC to restore the normal
transcriptome in the myocardium of mice chronically infected with T. cruzi.
Tanowitz et al., 2011 Cell Cycle T. cruzi Primary culture
(Endothelial cells)
Determine the potential molecular mechanisms by which the parasite-
derived TXA2 modulates Chagas disease progression and limits collateral
damage to organs.
doi:10.1371/journal.pone.0101131.t001
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Plasmodium experiments (Figure 6). The lowest scores were found
in the host domain in Leishmania and Toxoplasma experiments
(20%, Table S5). Plasmodium experiments had the lowest score in
the parasite domain (25%, Table S6) and Leishmania had the
lowest score in the experimental infection domain (30%, Table
S7). No Toxoplasma or Plasmodium experiment met all of the
criteria in any domain (Table S5, S6 and S7).
In contrast to all protozoan parasite experiments, the quality of
method reporting in the helminth model of infection by Trichuris
muris showed the highest scores in all three domains (Figure 6).
One Trichuris muris experiment [83] successfully scored 100% in
all three domains. Trichuris muris experiments reported signifi-
cantly more information than Trypanosoma (p,0.001), Plasmodi-
um (p,0.001), Schistosoma (p,0.001), Leishmania (p,0.01) and
Toxoplasma (p,0.01) experiments (Figure 6). However, the other
helminth model, Schistosoma sp., scored poorly with the second
lowest mean reported information (61.16%).Mycobacterium (mean
reported information 73.96%), the non-parasitic bacterial infec-
tion model, scored more highly than Trypanosoma (mean reported
information 65.46%) but this was not significant.
Validation of scoring methods
The papers from Trypanosoma experiments were initially scored
by the first and second authors. A specialist in trypanosomiasis
then independently scored these papers. The evaluation made by
the trypanosomiasis specialist scored 61.6% for the number of
criteria from the checklist met in the corpus of articles, whereas a
strict evaluation scored 65%. These evaluations scored 63.8% and
64.9% respectively after reviewing the results of both examina-
tions. A linear correlation test (Figure 7A) showed a strong and
significant linear correlation between the scores (r2 = 0.96; p,
0.0001); suggesting that the checklist items measure a common
domain and that the personal opinion of the coder does not have
an important impact on the scores. In addition, a Bland-Altman
test (Figure 7B) was used to verify the agreement between the two
evaluations. This analysis showed a good concordance as 16 points
were on the line of no difference and 21 fell within the 95% limits
of agreement (mean = 0.80 and SD: 62.91), verifying that the
scoring was consistent between the evaluators.
Discussion
In order to draw conclusions about the quality of method
information reported in articles and its impact on the replicability,
reproducibility and comparability of experimental work, we have
selected trypanosome infection models as a focus of study.
Trypanosomiasis as a complex disease is an appropriate example
to understand the importance of the subtlety of experimental
variables in the outcome of the modelled disease. Our results
indicate that the quality of method information reported in articles
about experimental infection with Trypanosoma spp is a cause for
concern and it has not shown improvement over time, despite
there being evidence that most of these variables do influence the
results.
Figure 2. Venn diagram summarising the quality of methods reporting in the three domains of Trypanosoma experiments. The
average and range of percentages scored of the quality of methods reporting is shown in brackets.
doi:10.1371/journal.pone.0101131.g002
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Many studies have demonstrated the genetic diversity of
Trypanosoma species [108,109], as well as the diversity of outcome
associated with different parasite strains [17]. The classically
described differences in humans infected with different subspecies
of T. brucei or lineages of T. cruzi are well recognized. T. brucei
rhodesiense causes acute disease and T. brucei gambiense causes a
more chronic infection [110]. T. b. gambiense is divided into two
groups which differ in phenotype including pathology [111]. In
addition, the cardiomyopathy and digestive forms of Chagas’
disease have been associated with T. cruzi lineage I and T. cruzi
lineage II respectively [112]. Strain differences have also been
observed in the three major strains of Toxoplasma, which vary
greatly in their virulence and infection outcome [113]. In addition,
isolates of Trichuris muris not only differ in virulence but can also
trigger changes in the immune response elicited in susceptible
hosts [114]; whereas eggs from different strains of Schistosoma
mansoni cause specific granulomatous responses [115]. Conse-
quently, reporting genus and species of the parasite is not enough;
the parasite strain must be reported and if the parasite is a new
isolate, it should be characterized.
Virulence of the parasite in all stages of its life cycle plays an
important role in the outcome of infection. For example, the
failure of laboratory experiments to develop successful malaria
vaccines has been attributed to the failure of models to include a
Figure 3. Scatter plots showing the relationship between the quality of methods reporting and the bibliometric indices. Journal
impact factor in which the papers were published (A), h-index of the corresponding author (B), and number of citations that the articles have received
in other publications (C). Spearman’s rank correlation coefficient r is shown alongside the regression lines. The figure shows that there is no
correlation between the quality of methods reporting and impact factor [r=20.04, p=0.868]. A similar result is shown with h-index, which was
searched using the full name of the corresponding author [r=20.12, p= 0.593; continuous line] and then filtered by the topic Trypanosom* [r=2
0.21, p=0.345; broken line]. There is a weak but significant correlation between the quality of methods reporting and the number of citations
recorded by Google Scholar [r=20.42, p= 0.044; broken line], but not by Web of Science [r=20.35, p= 0.105; continuous line]. In order to find out if
this association is due to a causal effect of the time of publication, a correlation between the number of citations and the time of publication was
done (D), and also a weak but significant correlation was shown with the records of Web of Science [r=0.42, p=0.046; continuous line], but not with
Google Scholar [r= 0.40, p=0.057; broken line].
doi:10.1371/journal.pone.0101131.g003
Assessing Methods Reporting in Parasitology
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e101131
skin stage, which is deemed integral to suppressing host immunity
and initiating tolerance to the parasite [116]. In T. cruzi, several
factors have been implicated in the formation of the infective
metacyclic stages. Long-term axenic cultures of T. cruzi exhibit a
lower capacity to transform into metacyclic trypomastigotes, in
comparison to those maintained by alternate invertebrate/
vertebrate passages [117]. In addition, the infectivity of T. cruzi
clones is modified when it is grown in different hosts; a clone
passaged through mice has been shown to be more virulent to
mice and guinea pigs than the same clone passaged through
guinea pigs, the virulence of which remained unchanged [118].
Infection route has also been shown to exert significant impact on
the overall course and outcome of infection. In Chagas disease, for
instance, the outbreaks associated with food/beverage consump-
tion display severe clinical features in comparison with those of
patients that have been infected with T. cruzi by vector
transmission [119]; a phenomenon that has been associated with
the sylvatic biodemes and genotypes of T. cruzi [120,121]. In
addition, in Toxoplasma infections, mice may be susceptible or
resistant to infection depending on whether an oral or intraper-
itoneal challenge is used [122].
Since gender and the corresponding sex steroids affect the
immune response [123,124] it is important to specify the gender of
experimental animals used. Sex-differences have been demon-
strated previously in several experimental infections. For example,
in BALB/k mice, males are more resistant to Toxoplasma gondii
than females [125]. Conversely, in BALB/c mice lacking IL-4, and
C57BL/6 p552/2 or p752/2 mice, it is the female mice that are
better at expelling Trichuris muris than males [84]. However, only
70% of Trypanosoma studies reported the sex of animals used in
the experimental infection and only 25% reported the gender of
animals used to maintain parasite stocks (Tables S1 and S2). In
experimental trypanosome infections a gender-related effect has
Figure 4. Scatter plots between the reported information in
Trypanosoma experiments and year of publication. The figure
shows that there is no correlation [p=0.711] and that between 2000
and 2012 the quality of methods reporting has remain constant
(arithmetic mean =65.5%).
doi:10.1371/journal.pone.0101131.g004
Figure 5. Diagram of articles about Trypanosomiasis[MeSH] published between 2000 and 2012. Number of articles published per
journal (black bars) and the percentage of methods reporting (red bars). The figure shows that the quality of method reporting is not related with the
number of papers published by any one of the journals.
doi:10.1371/journal.pone.0101131.g005
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been shown: using BALB/c mice infected with a natural dose of
vector-derived metacyclic trypomastigotes of T. cruzi (100
parasites/mouse) the peak of parasitaemia in males was about
four-fold higher than that in females [126]. Similarly, an
experimental infection with a strain of T. brucei brucei at 50%
of the mouse lethal dose showed that the female were more
trypanotolerant than the males and there was no evidence that this
was X-linked [127,128]. Housing conditions and social environ-
ment also affect the course of experimental trypanosome
infections. For example, the parasitaemia levels vary according
to whether the animals are kept individually or in a group due to
pheromones of the opposite sex [126,129]. Furthermore, hormon-
al profiles during the oestrous cycle are not only modified by the
parasite; such as T. congolense [130], but also by the light/dark
cycle conditions [131].
In the case of contradictory results, the reporting of the essential
parameters that describe a parasitic experimental infection can
help to determine the nature of their discrepancies. To exemplify
this issue, we have chosen two papers published in the journal
Infection and Immunity that were undertaken to assess the role of
Nitric Oxide (NO) in immunity to T. cruzi infection and their
experiments showed contradictory results. Vespa et al. claim that
NO is involved in control of T. cruzi-induced parasitaemia [20],
whereas Cummings et al. claim that NO is not required for control
of T. cruzi in the acute or chronic stages of the infection [23].
However, although these studies were carried out using female
mice on a C57BL/6 background, the experimental infections were
performed using different T. cruzi strains, which could explain, at
least in part, the differences in their findings: mice infected with
104 trypomastigotes of the Y strain showed peak parasitaemia at
day 8 that decreased thereafter [20], whereas mice infected with
103 trypomastigotes of the Brazil strain showed a peak at day 30
and decreased thereafter [23]. Moreover, although both infections
were performed with blood-derived trypomastigotes none of them
reported species, gender and age of the animals used to culture the
parasite; important parameters that modified the infectivity of T.
cruzi [117,118]. In addition, there is experimental evidence that
shows significant differences among parasitaemia curves between
older and younger BALB/c mice infected with a long-term mouse-
passaged clone of the T. cruzi isolate TolAc1; higher parasitaemia
levels were observed in older animals (31-day-old) with lower
inoculum (36104 trypomastigotes) than younger animals (8-day-
old) with higher inoculum (96104 trypomastigotes) [118]. How-
ever, the age of the animals used to evaluate the role of NO in the
control of T. cruzi infection was reported by Vespa et al. but not
by Cummings et al. [20,23]. Thus, these and other conditions that
could also influence the parasitaemia and, hence, the researched
outcome should be reported in order to understand the complexity
of these parasitoses.
Although the information collected through the checklist should
be reported for all Trypanosoma experiments, some information
could be inferred from the characteristics of the experimental
processes, although this depends on the level of expertise of
observers (i.e. non-experts and experts). In this way, a factor such
as the stage of the parasite used for a T. cruzi infection could be
easily inferred by an expert since he/she knows that the infectious
stage is the trypomastigote. Moreover, both experts and non-
experts could also infer many details of the conditions used in cell
cultures by assuming experimenters have opted for the most
commonly used parameters. For example temperature and CO2
atmosphere are usually set to 37uC and 5% of CO2. However,
neither experts nor non-experts could infer the species and strain
Figure 6. Box-percentile plot to compare the quality of methods reporting in parasitology experiments. Articles about
‘‘Trypanosomiasis’’[MeSH]; ‘‘Leishmaniasis’’[MeSH]; ‘‘Toxoplasmosis’’[MeSH]; ‘‘Malaria’’[MeSH]; ‘‘Trichuris’’[MeSH]; ‘‘Schistosoma’’[MeSH] and ‘‘Tuber-
culosis’’[MeSH]. The figure shows that the experimental model of colitis induced by Trichuris had the highest scores, followed by tuberculosis,
Trypanosoma, Toxoplasma, Leishmania, Plasmodium and Schistosoma experiments. P values less than 0.01 and 0.001 are represented by ** and ***
respectively.
doi:10.1371/journal.pone.0101131.g006
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of the parasite; age and gender of the host; or the inoculum used in
the infection assays, among others. Thus the validation of data
becomes a difficult or impossible task when there is not only not
enough information about the method used, but also most of the
missing information cannot be inferred, even by an expert.
Providing a high-quality description of the experimental method
is important not only to replicate and reproduce, but also to
compare and integrate that data and, hence, facilitate translational
discoveries. The issues found in reporting methods probably stem,
at least in part, from the current structure of scientific publishing,
which is not adequate to effectively communicate complex
experimental methods. This problem has been recognised, with
some journals already introducing editorial measures and methods
checklists in order to improve the quality of methods reporting
[132].
For the field of trypanosomiasis we have created a checklist to
guide parasitologists in reporting Trypanosoma experiments (see
Annex 1). This checklist included the minimum information that
should be provided when describing the parasite, host and
infection aspects of those experiments. Our checklist does not
cover aspects inherent to each possible experimental assay such as
those derived from omics and conventional technologies. In these
cases, the BioSharing catalogue [133] should be consulted for
checklists: e.g. the Minimum Information About a Microarray
Experiment (MIAME) and Proteomics Experiment (MIAPE); and
the Minimum Information for Publication of Quantitative Real-
Time PCR Experiments (MIQE). Moreover, there are other
guidelines such as the Minimum Information About a Cellular
Assay (MIACA) and the Animals in Research: Reporting In Vivo
Experiments (ARRIVE) that provide detailed descriptions of
experiments performed on cell and animal models.
In conclusion, it has become clear that biomedical science is
plagued by findings that cannot be reproduced and/or compared;
and the parasitology community is no stranger to this, as has been
shown by this study. Nevertheless, the scientific community that
works on trypanosomiases is small and many of them know each
other personally so in principle it should be possible to change the
way that Trypanosoma experiments are reported. However, it is
important that the scientific community as a whole is engaged with
that process. Finally, the checklist has been demonstrated to be
applicable to several different infection models and could be
implemented to improve the quality of methods reporting for all
infection experiments in principle.
Materials and Methods
Search strategy
The method of the literature review follows the recommenda-
tions outlined in the PRISMA guidelines [134]. A protocol was
designed to identify the method information reported in published
articles that utilised experimental infection with Trypanosoma
species, where the effects on gene expression –transcriptomics and
proteomics– of the host were studied. Criteria in three domains
were evaluated: characteristics and culture conditions of the
parasite, characteristics and maintenance conditions of the host
and the infection procedure. The protocol used here for capturing
data has not been previously published.
The literature search was conducted using Medline via
PubMed. The database was searched in April 2013 for articles
that were published between 1st January, 2000 and 31st December,
Figure 7. Linear correlation (A) and Bland-Altman (B) plots
between scores of method reporting in Trypanosoma experi-
ments. Evaluation based strictly on what was explicitly included in the
published paper (Evaluator 1) and on interpretations and assumptions
determined by an expert in the field (Evaluator 2).
doi:10.1371/journal.pone.0101131.g007
Table 2. Search terms used in PubMed.
Search Terms
Search 1 ‘‘Genes’’[MeSH] AND ‘‘Trypanosomiasis’’[MeSH]
Search 2 ‘‘Proteins’’[MeSH] AND ‘‘Trypanosomiasis’’[MeSH]
Search 3 ‘‘Microarray Analysis’’[MeSH] AND ‘‘Trypanosomiasis’’[MeSH]
Search 4 ‘‘Proteomics’’[MeSH] AND ‘‘Trypanosomiasis’’[MeSH]
doi:10.1371/journal.pone.0101131.t002
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2012 using the MeSH (Medical Subject Headings) terms as they
appear in Table 2. The PubMed Identifier (PMID) numbers were
used to identify those articles that were common between ‘‘Genes’’
AND ‘‘Trypanosomiasis’’ and ‘‘Proteins’’ AND ‘‘Trypanosomia-
sis’’. The search was not limited by study design or by language of
publication. The year 2000 was chosen because it was the year in
which the first rough draft of the human genome was completed
[135,136] and these data were used in many fields of medicine
including infectious disease. In addition, we chose to focus on gene
expression profiling in the host due to an experimental Trypano-
soma infection because it provides the broadest evidence about the
molecular physiopathology of trypanosomiasis.
In order to compare the quality of method reporting in
Trypanosoma experiments with the reporting of other parasitic
disease infections we collected a subset of Leishmania, Toxoplasma
and Plasmodium experimental infection models, since diseases
produced by them are also complex and considered public health
issues. In addition, as a comparative control of methods reporting
in experimental infections, we sought two models of worm
infection: one with a simple life cycle (Trichuris muris) and
Table 3. Checklist for the reporting of Trypanosoma experiments.
Topic Item# Description Does it meet?
Parasite information
General 1 Identify the species of the parasite
2 Identify the strain of the parasite
3 Identify the stage of the parasite used
Culture conditions for parasites grown in vivo 4 Identify the species and strain of the animal
5 Describe the age of the animal
6 Describe the gender of the animal
7 Identify the parasite collection sample
Culture conditions for parasites grown in vitro 8 Identify the cell type
9 Describe the culture medium used
10 Describe the supplements and antibiotics used
11 Describe the temperature and CO2 atmosphere of the culture
Time of growing 12 Describe the time of growing of the parasite prior to infection
Host information
Animals 13 Identify the species and strain of the animal
14 Describe the age of the animal
15 Describe the gender of the animal
16 Describe the housing conditions (light/dark cycle)
17 Describe the method of sacrifice
Cell 18 Identify the cell type
19 In primary culture, identify the organ/tissue from which cells come
20 In primary culture, describe the method of purification of the cells
21 Describe the culture medium used
22 Describe the supplements and antibiotics used
23 Describe the temperature and CO2 atmosphere of the culture
24 Describe the time of growing of the cells prior to infection
Experimental infection information
Animal 25 Describe the inoculum –parasites per animal- used
26 Describe the way of inoculation
27 Describe the medium of inoculation
28 Report the parasitaemia and the time in which the parasitaemia was measured
29 Report the mortality of the animals post-infection
Cell 30 Report the purity of the primary culture
31 Report the viability of cells prior infection
32 Describe the ratio –parasites per cell- used
33 Report the percentage of infected cells
Parasite 34 Report the viability of parasites prior infection
35 Describe the purity of infective forms of the parasite
36 Describe the time course (length) of infection
doi:10.1371/journal.pone.0101131.t003
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another with a complex life cycle (Schistosoma sp.); requiring
adaptation for survival in fresh water as free-living forms and as
parasites in snail intermediate and vertebrate definitive hosts. In
addition, we assessed tuberculosis infectious models in order to
have a general idea about the quality of method reporting in non-
parasitic infection models. Tuberculosis was chosen because it is
probably one of the most studied infectious disease.
The same search strategy was carried out where the MeSH term
‘‘Trypanosomiasis’’ was replaced with the following MeSH terms:
‘‘Leishmaniasis’’, ‘‘Toxoplasmosis’’, ‘‘Malaria’’, ‘‘Trichuris’’,
‘‘Schistosoma’’ and ‘‘Tuberculosis’’. To avoid selection bias, the
articles were randomly ordered and the first 10 articles for each
extra parasitosis and the non-parasitic infection model (Mycobac-
terium) that described gene expression profiling in the host due to
an experimental infection were selected.
Study selection was made by one reviewer and checked
independently by a second reviewer, any disagreement was
resolved by consensus or by discussion with a third reviewer.
Only primary research papers were included in the search. The
titles and abstracts of articles were reviewed and analysed in detail
to filter out those in which the experiments were performed on the
parasite or on vector insects and keep those done on the host. This
corpus of articles was then used to confirm eligibility and to extract
data.
Structure definition and data extraction
A checklist that contains the minimum information required
about the parasite, host and infection to describe an experiment
carried out with any Trypanosoma species was elaborated by
experts in the field of trypanosomiasis research and it is presented
in Table 3. Pre-analytical variables in the methods were prioritised
in this list because they are critical for interpretation of the results.
The terms were classified into three domains according to their
roles in a Trypanosoma experiment: the host, the parasite and the
infection. A data extraction sheet was developed to annotate the
information reported in the methods and results sections. Data
extraction and quality assessment were carried out by one author
and checked by a second reviewer, and inconsistencies were
discussed by both reviewers and consensus reached.
Bibliometric indices
Bibliometric parameters were used to determine if they were
associated with the quality of method reporting. The impact factor
(IF) of each journal was retrieved from the Institute for Scientific
Information (ISI) Web of Knowledge’s Journal Citation Reports
database science edition 2011. The number of citations was
measured by the total recorded for each article by Thomson
Scientific’s Web of Science and Google Scholar in May 2013. For
each corresponding author, the h-index was obtained through
Thomson Scientific’s Web of Science using a citation window up
to one year before the article was published. The h-index was
searched in two different ways: first, using the full name of the
corresponding author and second, filtering the result by topic,
using the term ‘‘Trypanosom*’’. The number of articles published
for each journal about trypanosomiasis was sought in PubMed
using the short name of the journals and the MeSH term
‘‘Trypanosomiasis’’. The search was filtered by time; from 1st
January, 2000 to 31st December, 2012.
Validity of scoring methods
An expert in trypanosomiasis tested the quality of reported
information on Trypanosoma experiments. The expert scored the
corpus of articles using the checklist that contains the minimum
information required to describe a Trypanosoma experiment
(Table 3). This evaluation was based strictly on what was explicitly
included in the published paper and its results are presented
throughout this article. The validity of this assessment was tested
based on its agreement with another evaluation based on
interpretations and assumptions determined by another expert in
the field in order to avoid bias of the retrieval results by
interpretation.
Statistical analysis
For each article, the percentage of reported information in each
article domain was obtained by direct counting. Linear and
Spearman’s rank correlations and Bland-Altman comparison were
calculated using STATA software [137] and the equivalence of
between scores obtained by the evaluators was determined by a
correlation test. Comparisons between experimental infection
models were performed using a one-way ANOVA in GraphPad
PRISM 4 software [138].
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